LE 250 Logo
Pill imprint LE 250 Logo has been identified as Levetiracetam 250 mg.
Levetiracetam is used in the treatment of seizures; epilepsy; bipolar disorder; neuralgia; new daily persistent headache (and more), and belongs to the drug class pyrrolidine anticonvulsants. Risk cannot be ruled out during pregnancy.
Levetiracetam 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Levetiracetam Images
- Imprint:
-
LE 250
Logo - Strength:
- 250 mg
- Color:
- Blue
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Pyrrolidine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Cobalt Laboratories Inc
More Levetiracetam resources
- Levetiracetam (Wolters Kluwer)
- Levetiracetam Extended-Release Tablets (Wolters Kluwer)
- Levetiracetam Solution (Wolters Kluwer)
- Levetiracetam Tablets (Wolters Kluwer)
- levetiracetam (Cerner Multum)
- levetiracetam (Micromedex) - Includes Dosage Information
- levetiracetam Intravenous (Micromedex) - Includes Dosage Information
- Levetiracetam (AHFS DI)
- Keppra Injection (FDA)
- Levetiracetam (FDA)
- Levetiracetam Extended Release Tablets (FDA)
- Levetiracetam Injection (FDA)
- Levetiracetam Solution (FDA)
- Levetiracetam (Wolters Kluwer)


